1. Market Research
  2. > Therapy Industry

Immunotherapy Industry, August 2016 Market Reports from Top Publishers

You might be interested in: Therapy, Bladder Cancer, Oncology, Ovarian Cancer, Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Nuclear Medicine, Pancreatic Cancer, Renal Cancer, Respiratory Disease, Blood Disease, Brain Cancer, Diabetes, Lymphoma, Respiratory Treatment, Transdermal Delivery, Allergy Immunotherapy, Anti-Infective.


 
1-10 of 75 reports for Immunotherapy

Purchase Reports From Reputable Market Research Publishers

T-Cell Immunotherapy for Cancer -  Pipeline Analysis

T-Cell Immunotherapy for Cancer - Pipeline Analysis

  • $ 1 500
  • Industry report
  • August 2016
  • by RNCOS

Cancer is a leading cause of death worldwide. According to GLOBOCAN 2012, the incidence of cancer is expected to increase from 14 Million in 2012 to approximately 21 Million by 2030. Although conventional ...

Immunotherapy in Oncology: Drug Pathway Analyzer

Immunotherapy in Oncology: Drug Pathway Analyzer

  • $ 4 410
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 1183 immunotherapy drugs known to affect more than 237 specific intracellular signaling pathways for the ...

Immunotherapy in Oncology Drug Pipeline Update

Immunotherapy in Oncology Drug Pipeline Update

  • $ 4 410
  • Company report
  • August 2016
  • by Bioseeker

Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the ...

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update

  • $ 2 700
  • Industry report
  • August 2016
  • by Bioseeker

BioSeeker’s Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and ...

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates , Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor  T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates , Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint

  • $ 3 800
  • Industry report
  • July 2016
  • by Kelly Scientific Publications

This report provides a comprehensive overview of the size of cancer immunotherapy market, the segmentation of the market, key players and the vast potential of therapies that are in clinical trials. Oncologic ...

T-cell Immunotherapy: Clinical Trial Tracker

T-cell Immunotherapy: Clinical Trial Tracker

  • $ 949
  • Industry report
  • July 2016
  • by Roots Analysis Private Ltd.

INTRODUCTION After years of research tracing back to the 18th century, a gamut of novel therapies namely, CAR-T, TCR and TIL therapies, have finally reached a point of maturity. These promising therapeutic ...

Global Allergy Immunotherapies Market 2016-2020

Global Allergy Immunotherapies Market 2016-2020

  • $ 2 500
  • Industry report
  • July 2016
  • by Infiniti Research Limited

About the Allergy Immunotherapies Market Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an established treatment for severe allergies such ...

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Interleukin 12 Subunit Beta (Cytotoxic Lymphocyte Maturation Factor 40 kDa Subunit or CLMF p40 or IL12 Subunit p40 NK Cell Stimulatory Factor Chain 2 or IL12B) - Pipeline Review, H1 2016 Summary Global ...

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016’, provides in depth analysis ...

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Glutamate Carboxypeptidase 2 (Folate Hydrolase or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly-Gamma-Glutamate Carboxypeptidase or EC 3.4.17.21) - Pipeline Review, H1 2016 Summary Global Markets ...

About 3 800 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

Car-T - Company Report, 2016

  • January 2016
    135 pages
  • Immunotherapy  

    Therapy  

    Cancer  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.